
Opinion|Videos|May 28, 2024
Hepatic Encephalopathy: Critical Insights and Closing Thoughts
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
3
Current and Emerging BCMAxCD3 Bispecifics
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5